Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials

The data report details the baseline characteristics and observed outcomes among patients included in a large US administrative claims database (Optum Labs Data Warehouse) and those enrolled in the pivotal phase III clinical trials examining apixaban, dabigratan, edoxaban and rivaroxaban versus warf...

Full description

Bibliographic Details
Main Authors: Peter A. Noseworthy, Xiaoxi Yao, Bernard J. Gersh, Ian Hargraves, Nilay D. Shah, Victor M. Montori
Format: Article
Language:English
Published: Elsevier 2017-10-01
Series:Data in Brief
Online Access:http://www.sciencedirect.com/science/article/pii/S2352340917303876